Bowman, CA
Barry Bowman, Dublin, CA US
Patent application number | Description | Published |
---|---|---|
20090185959 | Distributed networked ozonation system - Embodiments of the present invention provide a distributed networked ozonation system for ozonation of storage rooms containing fresh or perishable products, and also may be useful in other applications involving multiple ozonated zones. An exemplary embodiment uses a set of distributed ozone generators connected to a communication network. An exemplary ozone generator comprises an ozone sensor, an ozone-generating cell, and a controller, and also may comprise an air cooling unit with an ozone destruct air filter, so that the generator may be placed within an ozonated environment. The ozone level of the storage area may be under closed-loop feedback control. The controller may communicate with other controllers at the same site and with a site controller, which in turn may communicate with a remote controller. | 07-23-2009 |
Brett Bowman, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20110308527 | Method and Apparatus for Tubal Occlusion - A device for sterilizing females by occluding the uterotubal junction. The device includes a catheter with a releasable heat generating plug which is used to thermally damage the uterotubal junction and cause it to constrict around the plug, after which the plug is released from the catheter and left in place in the uterotubal junction. | 12-22-2011 |
Brett Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20150211079 | METHOD FOR DETECTING A MINORITY GENOTYPE - Disclosed are methods for detecting a minority genotype of a target nucleic acid. The disclosed method generally includes the steps of (a) deep sequencing at least a portion of the target nucleic acid; (b) using the deep sequencing results of (a) to detect the presence of variant nucleobases at one or more nucleotide reference positions within the target nucleic acid; (c) using the variant detection results generated in step (b) to perform a statistical analysis of whether the variants are significant; and (d) using the variant detection and variant significance results generated in steps (b) and (c) to perform a statistical analysis of whether a subset of sequences together exhibit a common set of significant variants. | 07-30-2015 |
Brian Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20130338466 | NERVE SURVEILLANCE ELECTRODE ASSEMBLY - A nerve surveillance electrode assembly for a surgical access instrument including a substrate, at least one electrode, at least one lead, and a connector such that the nerve surveillance electrode assembly may be selectively applied to a surgical access instrument in such a way that the nerve surveillance electrode assembly is positioned to detect nerves while the surgical access instrument is being advanced toward a surgical target site. | 12-19-2013 |
Brian Bowman, Livermore, CA US
Patent application number | Description | Published |
---|---|---|
20110246289 | CLICK MARKETPLACE SYSTEM AND METHOD WITH ENHANCED CLICK TRAFFIC AUCTIONS - A system for storing and redirecting an Internet user with an enhanced click traffic (ECT) unit between websites of interested parties which employs a distributed network of Click Generators to enhance click traffic and an intermediary website for registering interested partners and conducting an auction of the ECT, having the result of redirecting the Internet user to the most relevant online destination. | 10-06-2011 |
Brian Bowman, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20140114414 | DEVICES AND METHODS FOR SPINAL STABILIZATION AND INSTRUMENTATION - Apparatus and methods for providing spinal percutaneous delivery of an implant that can rigidly fixate the spinous process of a first superior bone and a second inferior bone of a functional spinal unit. In one aspect, the device comprises two bone abutment members connected via an interconnecting member. In another aspect, the method comprises implanting at least two spinal implant apparatus within a target disc space via an implantation apparatus. In another aspect, a placement instrument comprising an implant delivery segment, an anchor segment, and an articulating arm is disclosed. | 04-24-2014 |
20140277486 | METHODS AND APPARATUS FOR IMPLANTING AN INTERBODY DEVICE - A delivery device for inserting an interbody implant into an intervertebral space in a patient has an elongate tube with a channel and is sized to fit in an intervertebral space. The elongate tube has a proximal portion, a distal portion, a longitudinal axis, and a window with a longitudinal axis. The window is disposed adjacent the distal portion of the elongate tube and the longitudinal axis of the window is offset from the longitudinal axis of the elongate tube. The channel is sized to receive the interbody implant, and also the channel is configured such that the interbody implant is advanced therealong from the proximal region toward the distal region. The interbody implant is deployed into the intervertebral space from the window. | 09-18-2014 |
20150012098 | METHODS AND APPARATUS FOR IMPLANTING AN INTERBODY DEVICE - An interbody implant comprises one or more elongate members that have superior and inferior surfaces with a height, and medial and lateral surfaces having a width. The height is set so the implant fits into the intervertebral space. The width is less than the height. The interbody implant has a first configuration, a second configuration, and a third configuration. The interbody implant is inserted into the intervertebral space in the first configuration such that medial and lateral surfaces contact the vertebral bodies, and the interbody implant is then actuated into the second configuration such that superior and inferior surfaces engage the vertebral bodies. Actuation of the implant from the first configuration to the second configuration distracts the vertebral bodies. The implant is actuated into the third configuration where the width of the implant is greater than width of the implant in the first or the second configuration. | 01-08-2015 |
20150080973 | METHODS AND APPARATUS FOR AN INSERTION GUIDE DEVICE - A delivery instrument for placing an interbody implant into an intervertebral space of a patient comprises a plurality of elongated plates disposed adjacent one another. Each elongated plate has a proximal portion and a distal portion. The distal portion is sized and shaped to fit into the intervertebral space, and is configured to engage a vertebral body in the intervertebral space. An expandable member is coupled to the plurality of elongated plates so as to form an enclosed tube that is sized and shaped to receive the interbody implant. The expandable member allows for translation of the plurality of elongated plates relative to one another as the interbody implant passes through the tube. | 03-19-2015 |
Brian S. Bowman, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20130172895 | DEVICES, SYSTEMS AND METHODS FOR TISSUE MODIFICATION - Devices and methods of modifying tissue for low profile and ultra profile rongeur devices to treat spinal tissue. These devices may include a curved or curveable distal region; the cutting member may be configured to operate in the curved region. Also described herein are tissue modification devices that may be flexible or bendable for positioning in the tissue (including the spinal region) but can be made rigid once in position, or otherwise fixed in place to allow leverage when modifying the tissue. | 07-04-2013 |
Brian S. Bowman, Solana Beach, CA US
Patent application number | Description | Published |
---|---|---|
20110106167 | ADJUSTABLE SPINAL STABILIZATION SYSTEM - An adjustable spinal stabilization system having a flexible connection unit for non-rigid stabilization of the spinal column. In one embodiment, the spinal stabilization system includes a flexible connection unit having a tether running through a hollow portion of the flexible connection unit, wherein the tether limits bending of the flexible connection unit. In a further embodiment the tether is pre-tensioned. In a further embodiment, the tension upon or compression of the tether is adjustable. | 05-05-2011 |
Brian Scott Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20120209330 | Spinal Stabilization Device - A flexible connection unit for use in a spinal fixation device, including: a longitudinal member having first end portion, a second end portion and a flexible member interposed between the first end portion and the second end portion, at least one of the first end portion and the second end portion configured to be coupled to a first bone securing member; and a spacer located between the first and second end portions, wherein at least a portion of the flexible member passes through an axial channel of the spacer and wherein the spacer comprises a resilient element configured to be coupled to a second bone securing member. | 08-16-2012 |
20130274557 | DETACHABLE DILATOR BLADE - A dilator assembly includes a dilator and a retractor member that is configured to be removably attached to the dilator. | 10-17-2013 |
Brian Scott Bowman, Solana Beach, CA US
Patent application number | Description | Published |
---|---|---|
20140094852 | Spinal Stabilization Device - A flexible connection unit for use in a spinal fixation device that includes: a longitudinal member having first and second ends and a flexible member interposed between the first and second ends, at least one of the first end and second end configured to be engaged by a first bone securing member; and at least one spacer located between the first and second ends, the spacer comprising a resilient element and a ring element encircling at least a portion of the resilient element, wherein the ring element is configured to be engaged by a second bone securing member. | 04-03-2014 |
Brian Scott Bowman, Encinitas, CA US
Patent application number | Description | Published |
---|---|---|
20080234746 | Spinal stabilization device - A flexible connection unit for use in a spinal fixation device, including: a first end portion and a second end portion, at least one of the first end and second end configured to be engagable by a section of a first bone securing member; a flexible member located between the first and second ends, the flexible member permitting motion of the first end relative to the second end; and a transition area located between the first end and the flexible member, the transition area tapering in diameter from a first section of the transition area proximate to the first end toward a second section of the transition area proximate to the flexible member. | 09-25-2008 |
Brian T. Bowman, Escondido, CA US
Patent application number | Description | Published |
---|---|---|
20110276193 | ENERGY EFFICIENT LIGHTING SYSTEM - The present invention relates to an energy efficient lighting system, more particularly a system and method for controlling the individual power consumption and light output for each lighting luminary at a local level based upon a multitude of inputs whereby at least one of the inputs preferably is from central building control. Preferably, the ballast or lighting fixture is operatively associated with and preferably includes a microcontroller that processes all signals from sensors and other control devices including a building central control sensor that manages building power consumption and selects the most energy efficient input signal to power the lamps. The lighting system preferably includes a plurality of lighting fixtures and the lighting output of each fixture is determined on the local level by the microcontroller associated with and preferably in each circuit housing or ballast associated with the fixture. | 11-10-2011 |
Bruce Bowman, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20130332257 | SHARING PRIVATE DEVICES FOR CONTENT RENDERING - An apparatus and method for accessing a voluntary pool of devices for remote content rendering is disclosed herein. A brokering device receives a request from a content provider device to render content on a device, the request including the content to be rendered and specifying a type of the device on which the content is to be rendered. The brokering device also receives availability conditions from a test device. The brokering device selects the test device in accordance with the request and the availability conditions. The test device is instructed to fulfill the content rendering request. | 12-12-2013 |
20140006225 | AUTOMATIC DEVICE INVENTORY MANAGEMENT FOR DIFFERENT TYPES OF DEVICES | 01-02-2014 |
20140040361 | SYNCHRONIZED CONTENT DISPLAY ACROSS A PLURALITY OF DEVICES - An apparatus and method for synchronized content display across a plurality of devices are disclosed herein. Content specified at a first device is deployed to the rest of the plurality of devices that are of diverse device types to each other. The first device instructs the other devices to render the content at each of the respective devices according to the respective device's content viewer and configuration. The first device also instructs the other devices to achieve a certain setting or state pertaining to true rendering of the content depending on the type of content to be rendered. | 02-06-2014 |
20140040490 | AUTOMATIC CONNECTION OF COMPUTING DEVICES - In one embodiment, a method of connecting to a client computing device is provided. The method is performed at a computing device, and in this method a connection is made to the client computing device. An inventory of the client computing device is then accessed. This inventory is stored in a storage device accessible by way of a computer network. Here, the storage device is separate from the client computing device and the computing device. A connection failure between the computing device and the client computing device is detected and thereafter, the inventory from the storage device is retrieved by way of the computer network. A reconnection to the client computing device can then be made based on the retrieved inventory. | 02-06-2014 |
20140136944 | REAL TIME WEB DEVELOPMENT TESTING AND REPORTING SYSTEM - Elements of the geometry of the image of a webpage as rendered on at least one target browser are compared with elements of a baseline geometry of the webpage to determine the differences between elements of the baseline geometry of the webpage and elements of the respective geometries of the image of the webpage as rendered on the at least one target browser. The elements of the image may be determined by a software tool for determining elements of a document geometry, such as a DOM geometry service. Code such as JavaScript may be injected into the webpage for use in determining the elements of the geometry of the image of the webpage. A list of issues that web developers face may be generated and the above differences between respective elements may allow arriving at a solution for at least some of the issues in order to provide testing of webpage information in real time. | 05-15-2014 |
Charles Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140029482 | SIMULTANEOUS BIDIRECTIONAL TRANSMISSION FOR RADIO SYSTEMS - Disclosed are methods, systems, and apparatus for maximizing the spectral efficiency of a communications spectrum by providing a means to transmit information continuously in both directions of a radio link on the same center frequency at any given time. One embodiment may be directed to a method of communicating in a point-to-point radio system. The method may include receiving a first signal at a first antenna of a radio head. The first signal may include a transmitted data signal and interfering signals. The method continues by determining a correction signal from a transmitter of the radio head and processing the first signal to remove the interfering signals using the correction signal, and sending a second signal using a second antenna. The first and second signals may be sent and received at substantially the same time. | 01-30-2014 |
20140029485 | SIMULTANEOUS BIDIRECTIONAL TRANSMISSION FOR RADIO SYSTEMS - Disclosed are methods, systems, and apparatus for maximizing the spectral efficiency of a communications spectrum by providing a means to transmit information continuously in both directions of a radio link on the same center frequency at any given time. One embodiment may be directed to a method of communicating in a point-to-point radio system. The method may include receiving a first signal at a first antenna of a radio head. The first signal may include a transmitted data signal and interfering signals. The method continues by determining a correction signal from a transmitter of the radio head and processing the first signal to remove the interfering signals using the correction signal, and sending a second signal using a second antenna. The first and second signals may be sent and received at substantially the same time. | 01-30-2014 |
20140030977 | TRANSMITTER FOR POINT-TO-POINT RADIO SYSTEM - Embodiments of the present invention are directed to methods, apparatuses, and systems for implementing a point-to-point radio architecture in which the isolation needed between the transmitter and receiver may be achieved through the use of separate antennas. One embodiment is directed at a radio head comprising a transmitter configured to operate at a first frequency, a receiver configured to operate at a second frequency, and a processor coupled to both the transmitter and the receiver. The transmitter is further coupled to a first antenna interface coupled to a first antenna configured to transmit signals at the first frequency. The receiver is further coupled to a second antenna interface coupled to a second antenna configured to receive signals at the second frequency. | 01-30-2014 |
20140030979 | TRANSMITTER FOR POINT-TO-POINT RADIO SYSTEM - Embodiments of the present invention are directed to methods, apparatuses, and systems for implementing a point-to-point radio architecture in which the isolation needed between the transmitter and receiver may be achieved through the use of separate antennas. One embodiment is directed at a radio head comprising a transmitter configured to operate at a first frequency, a receiver configured to operate at a second frequency, and a processor coupled to both the transmitter and the receiver. The transmitter is further coupled to a first antenna interface coupled to a first antenna configured to transmit signals at the first frequency. The receiver is further coupled to a second antenna interface coupled to a second antenna configured to receive signals at the second frequency. | 01-30-2014 |
Christopher Bryan Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090318103 | EMBEDDED MODULE RECEIVER NOISE PROFILING - A self-test prediction system predicts the impact that a host device has on an embedded wireless device's receiver performance by recording the wireless device's received power. No carrier or pilot signal is necessary to predict the impact. The wireless device's embedded receiver monitors its own received power (e.g., RSSI) from any type of radiated noise from the host device. For receivers that do not provide RSS referenced to absolute power, an external reference tone can be used in order to scale the measured receiver carrier to noise or signal to noise data to an absolute power. The increase in measured received power on the wireless device's receiver correlates to the impact the host device will have on the embedded wireless device's receiver sensitivity performance, providing a faster approach with less external equipment than current approaches that use external equipment to simulate the wireless device's forward link signal. | 12-24-2009 |
David L. Bowman, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20120127187 | Error Check-Only Mode - Video display pipes may terminate with a FIFO (first-in first-out) buffer from which pixels are provided to a display controller to display the pixels on a graphics/video display. The display pipes may frequently process the pixels at a much higher rate than at which the display controller fetches the pixels from the FIFO buffer. In an error-checking only mode, the FIFO may be disabled, and an error-checking (e.g. CRC) block connected in front of the FIFO may receive the pixels processed by the display pipes as fast as the display pipes are capable of processing the pixels. Accordingly, the length of test/simulation time required to perform a test may be determined by the rate at which pixels are generated rather than the rate at which the display controller displays the pixels. It also becomes possible to perform testing/simulation in environments where a display is not supported or is not available. The results generated by the error-checking may be read and compared to an expected value to detect test pass/fail conditions. | 05-24-2012 |
Don Bowman, Bonita, CA US
Patent application number | Description | Published |
---|---|---|
20110232843 | SUBSTRATE PROCESSING APPARATUS WITH COMPOSITE SEAL - A seal for sealing an interface between a container and a lid of a process chamber. The seal comprises a first seal element and a second seal element that are arranged to seal the interface in series, with the second seal element being situated to encounter processing activity upstream of the fist seal element. The first seal element has a deflectable portion and a protrusion extending radially from the deflectable portion. The second seal element has a radially extending recess in which the protrusion of the first seal element is received. The protrusion and recess interlock to restrict separation and/or rotation of the first and second seal elements. Inclined surfaces of the first seal element interact with the second seal element to apply axial sealing forces to sealing surfaces of the second seal member. | 09-29-2011 |
Edward P. Bowman, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20090175881 | ANTIBODIES TO IL-17A - Engineered antibodies to human IL-17A are provided, as well as uses thereof. | 07-09-2009 |
20110038878 | ANTIBODIES TO IL-17A - Engineered antibodies to human IL-17A are provided, as well as uses thereof. | 02-17-2011 |
20110052596 | ANTIBODIES TO IL-17A - Engineered antibodies to human IL-17A are provided, as well as uses thereof. | 03-03-2011 |
20120156699 | Pathogenic TH17 Cells; related reagents and methods - Methods and compositions are provided for the treatment of immune disorders, such as autoimmune diseases, or cancers, involving combination therapy with agents that inhibit the development or maintenance of Th17 cells. Treatment regimens are provided in which an antagonist of a pro-inflammatory cytokine is administered for a time sufficient to alleviate signs and symptoms of an acute phase flare-up of the autoimmune disease, or cancer, and treatment with an antagonist of IL-23 is continued for a longer time to prevent recurrence of the acute event. Antagonists of PGE2 and CD161 are also disclosed for use in treatment of autoimmune, inflammatory and proliferative disorders. | 06-21-2012 |
20130287775 | COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS - Methods and compositions are provided for the treatment of immune disorders, such as autoimmune diseases, or cancers, involving combination therapy with agents that inhibit the development or maintenance of Th17 cells. Treatment regimens are provided in which an antagonist of a pro-inflammatory cytokine is administered for a time sufficient to alleviate signs and symptoms of an acute phase flare-up of the autoimmune disease, or cancer, and treatment with an antagonist of IL-23 is continued for a longer time to prevent recurrence of the acute event. Antagonists of PGE2 and CD161 are also disclosed for use in treatment of autoimmune, inflammatory and proliferative disorders. | 10-31-2013 |
Edward P. Bowman, San Carlos, CA US
Patent application number | Description | Published |
---|---|---|
20090285777 | Uses of Mammalian Cytokine; Related Reagents - Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule. | 11-19-2009 |
20110135597 | Uses of Mammalian Cytokine; Related Reagents - Provided are methods of treatment for skin disorders. In particular, treatment, the skin disorders are generally inflammatory skin disorders, including improper wound healing. Provided are methods of using of a cytokine molecule. | 06-09-2011 |
Edward Paul Bowman, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20100135998 | COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS - Methods and compositions are provided for the treatment of immune disorders, such as autoimmune diseases, or cancers, involving combination therapy with agents that inhibit the development or maintenance of Th17 cells. Treatment regimens are provided in which an antagonist of a pro-inflammatory cytokine is administered for a time sufficient to alleviate signs and symptoms of an acute phase flare-up of the autoimmune disease, or cancer, and treatment with an antagonist of IL-23 is continued for a longer time to prevent recurrence of the acute event. Antagonists of PGE2 and CD161 are also disclosed for use in treatment of autoimmune, inflammatory and proliferative disorders. | 06-03-2010 |
20100239590 | JOINT DESTRUCTION BIOMARKERS FOR ANTI-IL-17A THERAPY OF INFLAMMATORY JOINT DISEASE - Novel methods and drug products for treating inflammatory joint diseases such as rheumatoid arthritis and associated arthritides are disclosed. The methods and products employ various serum markers of bone and cartilage metabolism or destruction, including cartilage oligomer matrix protein (COMP) and Receptor activator of NFB ligand (RANKL), as biomarkers to assess the effect of IL-17A antagonists on joint destruction in inflammatory joint diseases. | 09-23-2010 |
Heath Bowman, Trabuco Canyon, CA US
Patent application number | Description | Published |
---|---|---|
20110301686 | Implant Delivery Device - A system for delivering an implant within a patient is disclosed. The activation of the heater coil causes the degradation, melting or reduction of a component that brings the heater coil into or out of electrical contact with another component, or causes the individual loops of the coil to contact each other, thereby resulting a notable change in resistance in the circuit supplying the heater coil with electricity. A core wire terminates prior to the distal end of the device, allowing for greater flexibility. | 12-08-2011 |
20130018409 | Packing Coil - An occlusion device formed of a microcoil having a three-dimensional relaxed state employing open looped portions interposed between closed loop portions. Planes defined by sequentially formed open looped and closed loop portions are neither coincident nor parallel to one another. | 01-17-2013 |
20130131711 | Embolic Device With Shaped Wire - Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras. | 05-23-2013 |
20140005713 | Obstruction Removal System | 01-02-2014 |
20140046359 | Shaped Removal Device - An obstruction removal device is described having a variable external profile shape comprising one or more smaller profile regions and one or more larger profile regions. | 02-13-2014 |
20140148830 | Matter Conveyance System - A matter conveyance system is located within a catheter and transports thrombus from a proximal portion of the catheter to a distal end of the catheter. In one example, the matter conveyance system is a screw or helix that rotates to cause movement of the thrombus. | 05-29-2014 |
20140277013 | Multi-Component Obstruction Removal System And Method - An obstruction removal device is described having a retrieval component used to engage an obstruction within the vasculature and a sheath component that is capable of inverting to fold over the obstruction and the retrieval component. The sheath component helps contain the obstruction and minimizes trauma to the blood vessel during the removal process. | 09-18-2014 |
20150173772 | Device Delivery System - A catheter system utilizing one or more sensors is described. The catheter can be used as part of an embolic coil system, guidewire system, or combined embolic coil/guidewire system where the devices interact with the catheter system. A variable detachment embolic coil system and guidewire system are also described. | 06-25-2015 |
20150173773 | Catheter System - A catheter with one or more heated or detachable sections is described. The catheter may be useful for liquid embolic delivery, where the heated or detachable sections may help free the catheter when stuck to liquid embolic during delivery. An instrumented catheter is also described. | 06-25-2015 |
20150174370 | Electrically-Responsive Hydrogels - Implants comprising electrically-responsive hydrogel are described. Systems to provide electricity to induce response in hydrogel-containing implants are described. Methods for utilizing said system and methods for utilizing said hydrogel-containing implants are described. | 06-25-2015 |
20150289879 | Implant Delivery System - A system and method of delivering and detaching an implant within a body of a patient is described. A tether connects an implant with a delivery device. The delivery device includes a heater through which the tether passes. The inner lumen of the delivery system pusher may accommodate the lead wires which connect to the heater. | 10-15-2015 |
20160058459 | Obstruction Removal System - An obstruction removal device is described, having one or more engaging members which can engage portions of the clot. The one or more engaging members have a collapsed, delivery state, and an expanded, deployed state. | 03-03-2016 |
James C. Bowman, Pescadero, CA US
Patent application number | Description | Published |
---|---|---|
20110090220 | ORDER-PRESERVING DISTRIBUTED RASTERIZER - One embodiment of the present invention sets forth a technique for rendering graphics primitives in parallel while maintaining the API primitive ordering. Multiple, independent geometry units perform geometry processing concurrently on different graphics primitives. A primitive distribution scheme delivers primitives concurrently to multiple rasterizers at rates of multiple primitives per clock while maintaining the primitive ordering for each pixel. The multiple, independent rasterizer units perform rasterization concurrently on one or more graphics primitives, enabling the rendering of multiple primitives per system clock. | 04-21-2011 |
20110102448 | VERTEX ATTRIBUTE BUFFER FOR INLINE IMMEDIATE ATTRIBUTES AND CONSTANTS - One embodiment of the present invention sets forth a technique for providing primitives and vertex attributes to the graphics pipeline. A primitive distribution unit constructs the batches of primitives and writes inline attributes and constants to a vertex attribute buffer (VAB) rather than passing the inline attributes directly to the graphics pipeline. A batch includes indices to attributes, where the attributes for each vertex are stored in a different VAB. The same VAB may be referenced by all of the vertices in a batch or different VABs may be referenced by different vertices in one or more batches. The batches are routed to the different processing engines in the graphics pipeline and each of the processing engines reads the VABs as needed to process the primitives. The number of parallel processing engines may be changed without changing the width or speed of the interconnect used to write the VABs. | 05-05-2011 |
20110109638 | RESTART INDEX THAT SETS A TOPOLOGY - One embodiment of the present invention sets forth a technique for reducing overhead associated with transmitting primitive draw commands from memory to a graphics processing unit (GPU). Command pairs comprising an end draw command and a begin draw command associated with a conventional graphics application programming interface (API) are selectively replaced with a new construct. The new construct is a reset topology index, which implements a combined function of the end draw command and begin draw command. The new construct improves efficiency by reducing total data transmitted from memory to the GPU. | 05-12-2011 |
20140152652 | ORDER-PRESERVING DISTRIBUTED RASTERIZER - One embodiment of the present invention sets forth a technique for rendering graphics primitives in parallel while maintaining the API primitive ordering. Multiple, independent geometry units perform geometry processing concurrently on different graphics primitives. A primitive distribution scheme delivers primitives concurrently to multiple rasterizers at rates of multiple primitives per clock while maintaining the primitive ordering for each pixel. The multiple, independent rasterizer units perform rasterization concurrently on one or more graphics primitives, enabling the rendering of multiple primitives per system clock. | 06-05-2014 |
John Bowman, El Cerrito, CA US
Patent application number | Description | Published |
---|---|---|
20160055495 | SYSTEMS AND METHODS FOR ESTIMATING DEMAND - A method for computing a demand probability for one or more products. The method can include establishing one or more similarities between one or more regional segments and combining the one or more regional segments into one or more clusters based on the one or more similarities. The method can also include executing one or more computer instructions on one or more processors for determining a demand probability distribution across the one or more clusters for the one or more products based on historical data and delivering the one or more products to the one or more clusters based on the demand probability distribution. | 02-25-2016 |
Josh Bowman, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20150054389 | HOMOPOLAR PERMANENT-MAGNET-BIASED ACTION MAGNETIC BEARING WITH AN INTEGRATED ROTATIONAL SPEED SENSOR - Radial poles are placed around a radial actuator target mounted on a body. The poles are separated from a cylindrical surface of the target by radial gaps and adapted to communicate a magnetic flux with it. The radial poles are equipped with electrical control windings and magnetically coupled to form magnetic control circuits. A flux return pole is adjacent to the body, separated from it by an air gap and adapted to communicate a magnetic flux with the radial actuator target. A permanent magnet generates a magnetic bias flux in the magnetic bias circuit formed by the radial actuator target, the radial poles and the magnetic flux return pole. A radial force is exerted on the actuator when the control windings are energized with a current. A Hall effect sensor measures bias magnetic field in the air gap between the magnetic flux return pole and the body. A feature on a body is adapted to produce a circumferentially local discontinuity in the magnetic field measured by the Hall effect sensor as the body rotates. | 02-26-2015 |
Kenneth Bowman, Alta Loma, CA US
Patent application number | Description | Published |
---|---|---|
20130029011 | PET TREAT - Provided are treats having an outer portion and an inner portion which contains a filing. The filling may include ground or diced meat and further includes additional ingredients for health benefits or palatability. The treats are highly palatable to pets and therefore very well-suited to delivery of health ingredients. | 01-31-2013 |
Kevin Dale Bowman, Costa Mesa, CA US
Patent application number | Description | Published |
---|---|---|
20090007155 | Expander-based solution to the dynamic STP address problem - The persistent binding of STP SAS addresses to SATA devices is disclosed so that SATA devices can be moved to different insertion points (ports) within a SAS expander and still properly receive I/O requests. When a SATA device is inserted into the SAS expander, it is interrogated to obtain information about the attached device. This information may be combined using a hashing function to obtain a unique ID for the SATA device. A table can be used to assign a STP SAS address to the Phy connected to the device based in the unique ID. In this manner, the same STP SAS address will be assigned to the Phy connected to a particular SATA device, regardless of where the device is connected to the SAS expander. | 01-01-2009 |
Krister Bowman, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20100139294 | Cooling System Having A Bypass Valve To Regulate Fluid Flow - A fluid chiller system supplying cold fluid to a therapeutic wrap, in which a minimum level of fluid flow is provided through the heat exchange coils to insure that the fluid in the coils does not freeze. A fluid flow meter or pressure sensor connected inline with the inlet port of the chiller unit measures a level of fluid flow. A controller is connected to the flow meter or pressure sensor and a bypass valve, wherein based on a signal from the flow meter or pressure sensor, the controller adjusts the bypass valve to provide a predetermined level of fluid flow into the inlet port of the chiller unit, in order to prevent the heat exchange coils from freezing, if the flow through the wrap is blocked. | 06-10-2010 |
20100145421 | Therapeutic Cooling and/or Heating System Including A Thermo-Conductive Material - In general, the present invention incorporates a cooling or heating wrap having internal channels to circulate a chilled or warmed fluid, with one or more layers of a thermo-conductive material to eliminate air pockets or gaps between the wrap and a human or animal body part. The thermo-conductive material may be applied directly to the human or animal skin and/or body part, may be encapsulated in a separate unit, or may be integrated into the wrap itself. The thermo-conductive material acts like a heat conduction medium between the heat exchanging wrap and the anatomical body part, to increase the therapeutic effect of the wrap. | 06-10-2010 |
20110098792 | THERAPEUTIC WRAP - Temperature-controlled therapy wrap for treatment of at least a portion of an animate body including a fluid bladder including an inlet, an outlet, and at least one fluidic channel connecting the inlet to the outlet; and a thermal insulating member on the fluid bladder only directly adjacent the inlet and extending along the at least one fluidic channel. The therapy wrap may be adapted to compensate for a temperature delta in the wrap. The therapy wrap may include an insulating layer of one or more insulating members. The insulating layer is dimensioned and configured to have different coefficients of heat transfer. The insulating layer may have varying thicknesses and materials to achieve varying heat transfer rates. Also disclosed is a method of administering a temperature-controlled treatment to an anatomical body part. | 04-28-2011 |
20110098793 | TEMPERATURE AND FLOW CONTROL METHODS IN A THERMAL THERAPY DEVICE - A controlled temperature therapy system has a pump, a reservoir, and a therapy component. The reservoir has an inlet in communication with the therapy component and an outlet in communication with the pump. The reservoir may also include a baffle adjacent the outlet. The inlet may be a movable inlet, a nozzle or include a flow directing surface. | 04-28-2011 |
20120172774 | REINFORCED THERAPEUTIC WRAP AND METHOD - A therapy wrap for treatment of at least a portion of an animate body having improved kink resistance. The therapy wrap may be selectively reinforced for improved kink resistance in only a portion of the wrap. The reinforcement may decrease the kink radius. The wrap may include a kink reducer in all or only a selected kink-prone region. The kink reducer may be selectively configured attachment points or spot welds. The therapy wrap may include a reinforcement layer of one or more discrete reinforcement members. The wrap may be formed by pre-tensioning the material layers while forming the fluid bladder and/or gas pressure bladder. The therapy wrap may be adapted to compensate for conditions that normally cause kinking of the wrap or buckling of the fluidic channels. Also disclosed are methods of manufacturing the wrap and methods of administering a temperature-controlled treatment to an anatomical body part. | 07-05-2012 |
20140142473 | REINFORCED THERAPEUTIC WRAP AND METHOD - A therapy wrap for treatment of at least a portion of an animate body having improved kink resistance. The therapy wrap may be selectively reinforced for improved kink resistance in only a portion of the wrap. The reinforcement may decrease the kink radius. The wrap may include a kink reducer in all or only a selected kink-prone region. The kink reducer may be selectively configured attachment points or spot welds. The therapy wrap may include a reinforcement layer of one or more discrete reinforcement members. The wrap may be formed by pre-tensioning the material layers while forming the fluid bladder and/or gas pressure bladder. The therapy wrap may be adapted to compensate for conditions that normally cause kinking of the wrap or buckling of the fluidic channels. Also disclosed are methods of manufacturing the wrap and methods of administering a temperature-controlled treatment to an anatomical body part. | 05-22-2014 |
20140243939 | TEMPERATURE AND FLOW CONTROL METHODS IN A THERMAL THERAPY DEVICE - A controlled temperature therapy system has a pump, a reservoir, and a therapy component. The reservoir has an inlet in communication with the therapy component and an outlet in communication with the pump. The reservoir may also include a baffle adjacent the outlet. The inlet may be a moveable inlet, a nozzle or include a flow directing surface. | 08-28-2014 |
Leif Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20160066843 | SYSTEMS AND METHODS FOR LEVERAGING SMARTPHONE FEATURES IN CONTINUOUS GLUCOSE MONITORING - The present embodiments harness a wide variety of capabilities of modern smartphones, and combine these capabilities with information from a continuous glucose monitor to provide diabetics and related people with more information than the continuous glucose monitor can provide by itself. The increased information provides the diabetic with an increased likelihood of good diabetes management for better health. | 03-10-2016 |
Leif Bowman, Livermore, CA US
Patent application number | Description | Published |
---|---|---|
20100198033 | FLEXIBLE INDWELLING BIOSENSOR, FLEXIBLE INDWELLING BIOSENSOR INSERTION DEVICE, AND RELATED METHODS - A flexible indwelling biosensor includes an elongated framework formed from a flexible material (e.g., a Nitinol strip) with a body portion, a sharp head, a distal end, and a proximal end. The flexible indwelling sensor also includes a biosensor (such as an interstitial fluid glucose sensor) integrated with the elongated framework with the biosensor having a sensing element disposed over (for example, on or suspended over) at least one of the body portion or sharp head of the elongated framework. Moreover, the sharp head is disposed at the distal end of the elongated framework and the sharp head and at least the sensing element of the biosensor are configured for insertion into a target site (for example, a subcutaneous target site). | 08-05-2010 |
20100261987 | METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT - Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations. | 10-14-2010 |
Leif N. Bowman, Livermore, CA US
Patent application number | Description | Published |
---|---|---|
20110028901 | MEDICATION DELIVERY SYSTEM AND MONITOR - Systems and methods for the delivery and monitoring of a medication, such as insulin, to a recipient are provided. An exemplary feature-rich system comprises an infusion pump with a control system for controlling medication delivery by the infusion pump and a bolus estimator for estimating an appropriate amount of medication for delivery by the control system with the infusion pump. Estimating the appropriate amount of medication for delivery is based upon one or more settings which each vary according to a setting profile. In other embodiments, the control system comprises a suspend function for temporarily suspending medication delivery by the infusion pump, an alarm profile function for programming a variable alarm volume of the alarm and a simplified menu for controlling the dual wave bolus delivery function. | 02-03-2011 |
20110295341 | MEDICATION DELIVERY SYSTEM AND MONITOR - Systems and methods for the delivery and monitoring of a medication, such as insulin, to a recipient are provided. An exemplary feature-rich system comprises an infusion pump with a control system for controlling medication delivery by the infusion pump and a bolus estimator for estimating an appropriate amount of medication for delivery by the control system with the infusion pump. Estimating the appropriate amount of medication for delivery is based upon one or more settings which each vary according to a setting profile. In other embodiments, the control system comprises a suspend function for temporarily suspending medication delivery by the infusion pump, an alarm profile function for programming a variable alarm volume of the alarm and a simplified menu for controlling the dual wave bolus delivery function. | 12-01-2011 |
20120035547 | MEDICATION DELIVERY SYSTEM AND MONITOR - Systems and methods for the delivery and monitoring of a medication, such as insulin, to a recipient are provided. An exemplary feature-rich system comprises an infusion pump with a control system for controlling medication delivery by the infusion pump and a bolus estimator for estimating an appropriate amount of medication for delivery by the control system with the infusion pump. Estimating the appropriate amount of medication for delivery is based upon one or more settings which each vary according to a setting profile. In other embodiments, the control system comprises a suspend function for temporarily suspending medication delivery by the infusion pump, an alarm profile function for programming a variable alarm volume of the alarm and a simplified menu for controlling the dual wave bolus delivery function. | 02-09-2012 |
20120041414 | MEDICATION DELIVERY SYSTEM AND MONITOR - Systems and methods for the delivery and monitoring of a medication, such as insulin, to a recipient are provided. An exemplary feature-rich system comprises an infusion pump with a control system for controlling medication delivery by the infusion pump and a bolus estimator for estimating an appropriate amount of medication for delivery by the control system with the infusion pump. Estimating the appropriate amount of medication for delivery is based upon one or more settings which each vary according to a setting profile. In other embodiments, the control system comprises a suspend function for temporarily suspending medication delivery by the infusion pump, an alarm profile function for programming a variable alarm volume of the alarm and a simplified menu for controlling the dual wave bolus delivery function. | 02-16-2012 |
20120041415 | MEDICATION DELIVERY SYSTEM AND MONITOR - Systems and methods for the delivery and monitoring of a medication, such as insulin, to a recipient are provided. An exemplary feature-rich system comprises an infusion pump with a control system for controlling medication delivery by the infusion pump and a bolus estimator for estimating an appropriate amount of medication for delivery by the control system with the infusion pump. Estimating the appropriate amount of medication for delivery is based upon one or more settings which each vary according to a setting profile. In other embodiments, the control system comprises a suspend function for temporarily suspending medication delivery by the infusion pump, an alarm profile function for programming a variable alarm volume of the alarm and a simplified menu for controlling the dual wave bolus delivery function. | 02-16-2012 |
20120108934 | CONTINUOUS ANALYTE MONITOR DATA RECORDING DEVICE OPERABLE IN A BLINDED MODE - A system is provided including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. The data received from the continuous analyte sensor may be used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement. The device may provide for toggling between modes that allow or prevent the display of glucose concentration values associated with the continuous glucose sensor. | 05-03-2012 |
20130035575 | SYSTEMS AND METHODS FOR DETECTING GLUCOSE LEVEL DATA PATTERNS - Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges. | 02-07-2013 |
20130035865 | SYSTEMS AND METHODS FOR DETECTING GLUCOSE LEVEL DATA PATTERNS - Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges. | 02-07-2013 |
20130035871 | SYSTEMS AND METHODS FOR DETECTING GLUCOSE LEVEL DATA PATTERNS - Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges. | 02-07-2013 |
20140005505 | USE OF SENSOR REDUNDANCY TO DETECT SENSOR FAILURES | 01-02-2014 |
20140012117 | SYSTEMS AND METHODS FOR LEVERAGING SMARTPHONE FEATURES IN CONTINUOUS GLUCOSE MONITORING - The present embodiments harness a wide variety of capabilities of modern smartphones, and combine these capabilities with information from a continuous glucose monitor to provide diabetics and related people with more information than the continuous glucose monitor can provide by itself. The increased information provides the diabetic with an increased likelihood of good diabetes management for better health. | 01-09-2014 |
20140012118 | SYSTEMS AND METHODS FOR LEVERAGING SMARTPHONE FEATURES IN CONTINUOUS GLUCOSE MONITORING - The present embodiments harness a wide variety of capabilities of modern smartphones, and combine these capabilities with information from a continuous glucose monitor to provide diabetics and related people with more information than the continuous glucose monitor can provide by itself. The increased information provides the diabetic with an increased likelihood of good diabetes management for better health. | 01-09-2014 |
20140012510 | SYSTEMS AND METHODS FOR LEVERAGING SMARTPHONE FEATURES IN CONTINUOUS GLUCOSE MONITORING - The present embodiments harness a wide variety of capabilities of modern smartphones, and combine these capabilities with information from a continuous glucose monitor to provide diabetics and related people with more information than the continuous glucose monitor can provide by itself. The increased information provides the diabetic with an increased likelihood of good diabetes management for better health. | 01-09-2014 |
20140012511 | SYSTEMS AND METHODS FOR LEVERAGING SMARTPHONE FEATURES IN CONTINUOUS GLUCOSE MONITORING - The present embodiments harness a wide variety of capabilities of modern smartphones, and combine these capabilities with information from a continuous glucose monitor to provide diabetics and related people with more information than the continuous glucose monitor can provide by itself. The increased information provides the diabetic with an increased likelihood of good diabetes management for better health. | 01-09-2014 |
20140114157 | CONTINUOUS ANALYTE MONITOR DATA RECORDING DEVICE OPERABLE IN A BLINDED MODE - A system is provided for monitoring analyte in a host, including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. In one embodiment, the device includes a single point analyte monitor, from which it obtains an analyte value, and is configured to display only single point analyte measurement values, and not any analyte measurement values associated with data received from the continuous analyte sensor. Instead, data received from the continuous analyte sensor is used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement. In another embodiment, the device provides for toggling between two modes, with one mode that allows for display of glucose concentration values associated with the continuous glucose sensor and a second mode that prevents the display of glucose concentration values associated with the continuous glucose sensor. | 04-24-2014 |
20140114161 | METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT - Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations. | 04-24-2014 |
20140187889 | REMOTE MONITORING OF ANALYTE MEASUREMENTS - Methods and apparatus, including computer program products, are provided for remote monitoring. In some example implementations, there is provided a method. The method may include receiving, at a remote monitor, a notification message representative of an event detected, by a server, from analyte sensor data obtained from a receiver monitoring an analyte state of a host; presenting, at the remote monitor, the notification message to activate the remote monitor, wherein the remote monitor is configured by the server to receive the notification message to augment the receiver monitoring of the analyte state of the host; accessing, by the remote monitor, the server, in response to the presenting of the notification message; and receiving, in response to the accessing, information including at least the analyte sensor data. Related systems, methods, and articles of manufacture are also disclosed. | 07-03-2014 |
20140188398 | REMOTE MONITORING OF ANALYTE MEASUREMENTS - Methods and apparatus, including computer program products, are provided for remote monitoring. In some example implementations, there is provided a method. The method may include receiving, at a remote monitor, a notification message representative of an event detected, by a server, from analyte sensor data obtained from a receiver monitoring an analyte state of a host; presenting, at the remote monitor, the notification message to activate the remote monitor, wherein the remote monitor is configured by the server to receive the notification message to augment the receiver monitoring of the analyte state of the host; accessing, by the remote monitor, the server, in response to the presenting of the notification message; and receiving, in response to the accessing, information including at least the analyte sensor data. Related systems, methods, and articles of manufacture are also disclosed. | 07-03-2014 |
20150118658 | ADAPTIVE INTERFACE FOR CONTINUOUS MONITORING DEVICES - Systems and methods that continuously adapt aspects of a continuous monitoring device based on collected information to provide an individually tailored configuration are described. The adaptations may include adapting the user interface, the alerting, the motivational messages, the training, and the like. Such adaptation can allow a patient to more readily identify and understand the information provided by/via the device. | 04-30-2015 |
20150118668 | ADAPTIVE INTERFACE FOR CONTINUOUS MONITORING DEVICES - Systems and methods that continuously adapt aspects of a continuous monitoring device based on collected information to provide an individually tailored configuration are described. The adaptations may include adapting the user interface, the alerting, the motivational messages, the training, and the like. Such adaptation can allow a patient to more readily identify and understand the information provided by/via the device. | 04-30-2015 |
20150119655 | ADAPTIVE INTERFACE FOR CONTINUOUS MONITORING DEVICES - Systems and methods that continuously adapt aspects of a continuous monitoring device based on collected information to provide an individually tailored configuration are described. The adaptations may include adapting the user interface, the alerting, the motivational messages, the training, and the like. Such adaptation can allow a patient to more readily identify and understand the information provided by/via the device. | 04-30-2015 |
20150119668 | ADAPTIVE INTERFACE FOR CONTINUOUS MONITORING DEVICES - Systems and methods that continuously adapt aspects of a continuous monitoring device based on collected information to provide an individually tailored configuration are described. The adaptations may include adapting the user interface, the alerting, the motivational messages, the training, and the like. Such adaptation can allow a patient to more readily identify and understand the information provided by/via the device. | 04-30-2015 |
20150120317 | ADAPTIVE INTERFACE FOR CONTINUOUS MONITORING DEVICES - Systems and methods that continuously adapt aspects of a continuous monitoring device based on collected information to provide an individually tailored configuration are described. The adaptations may include adapting the user interface, the alerting, the motivational messages, the training, and the like. Such adaptation can allow a patient to more readily identify and understand the information provided by/via the device. | 04-30-2015 |
20150130633 | INDICATOR AND ANALYTICS FOR SENSOR INSERTION IN A CONTINUOUS ANALYTE MONITORING SYSTEM AND RELATED METHODS - The present embodiments provide systems and methods for, among others, tracking sensor insertion locations in a continuous analyte monitoring system. Data gathered from sensor sessions can be used in different ways, such as providing a user with a suggested rotation of insertion locations, correlating data from a given sensor session with sensor accuracy and/or sensor session length, and providing a user with a suggested next insertion location based upon past sensor accuracy and/or sensor session length at that location. | 05-14-2015 |
20150130634 | INDICATOR AND ANALYTICS FOR SENSOR INSERTION IN A CONTINUOUS ANALYTE MONITORING SYSTEM AND RELATED METHODS - The present embodiments provide systems and methods for, among others, tracking sensor insertion locations in a continuous analyte monitoring system. Data gathered from sensor sessions can be used in different ways, such as providing a user with a suggested rotation of insertion locations, correlating data from a given sensor session with sensor accuracy and/or sensor session length, and providing a user with a suggested next insertion location based upon past sensor accuracy and/or sensor session length at that location. | 05-14-2015 |
20150135118 | INDICATOR AND ANALYTICS FOR SENSOR INSERTION IN A CONTINUOUS ANALYTE MONITORING SYSTEM AND RELATED METHODS - The present embodiments provide systems and methods for, among others, tracking sensor insertion locations in a continuous analyte monitoring system. Data gathered from sensor sessions can be used in different ways, such as providing a user with a suggested rotation of insertion locations, correlating data from a given sensor session with sensor accuracy and/or sensor session length, and providing a user with a suggested next insertion location based upon past sensor accuracy and/or sensor session length at that location. | 05-14-2015 |
20150289821 | GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE - Systems and methods are disclosed that employ several or numerous factors in the determination of a glycemic urgency index (GUI), which may be based on a measured blood glucose level as well as other factors. The other factors may include time derivatives of the glucose level and/or other factors, e.g., user—entered data, data measured by other sensors or received from a network source, or historical data. The GUI is then presented to the user in an interesting way, e.g., via a background color or other inconspicuous notifier, e.g., on a mobile device such as a smart phone. The GUI may also be employed in the triggering of actionable alerts and alarms on an electronic device for the user. The GUI, or another index calculated from combinations of the variables and parameters described, may further be employed to drive a medicament delivery device such as a pump. | 10-15-2015 |
20150289823 | GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE - Systems and methods are disclosed that employ several or numerous factors in the determination of a glycemic urgency index (GUI), which may be based on a measured blood glucose level as well as other factors. The other factors may include time derivatives of the glucose level and/or other factors, e.g., user-entered data, data measured by other sensors or received from a network source, or historical data. The GUI is then presented to the user in an interesting way, e.g., via a background color or other inconspicuous notifier, e.g., on a mobile device such as a smart phone. The GUI may also be employed in the triggering of actionable alerts and alarms on an electronic device for the user. The GUI, or another index calculated from combinations of the variables and parameters described, may further be employed to drive a medicament delivery device such as a pump. | 10-15-2015 |
20160058353 | CONTINUOUS ANALYTE MONITOR DATA RECORDING DEVICE OPERABLE IN A BLINDED MODE - A system is provided for monitoring analyte in a host, including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. In one embodiment, the device includes a single point analyte monitor, from which it obtains an analyte value, and is configured to display only single point analyte measurement values, and not any analyte measurement values associated with data received from the continuous analyte sensor. Instead, data received from the continuous analyte sensor is used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement. In another embodiment, the device provides for toggling between two modes, with one mode that allows for display of glucose concentration values associated with the continuous glucose sensor and a second mode that prevents the display of glucose concentration values associated with the continuous glucose sensor. | 03-03-2016 |
20160058380 | SYSTEMS AND METHODS FOR SECURING A CONTINUOUS ANALYTE SENSOR TO A HOST - Adhesive pad systems that provide longer lasting adherence of the mounting unit to the host's skin are provided. Some systems include a reinforcing overlay that at least partially covers the adhesive pad. The reinforcing overlay may be removable without disturbing the sensor so that the overlay may be replaceable. | 03-03-2016 |
20160081597 | SYSTEM AND METHOD FOR MODE SWITCHING - Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user's interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like. | 03-24-2016 |
Leif N. Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20150119667 | DEVICES USED IN CONNECTION WITH CONTINUOUS ANALYTE MONITORING THAT PROVIDE THE USER WITH ONE OR MORE NOTIFICATIONS, AND RELATED METHODS - Devices and methods for providing a user with alerts are provided. The alerts may take different forms, such as an output to a display, a speaker, a vibration module, a shock module, etc. The alerts provide the user with sufficient information to take appropriate action, but the devices may be of limited functionality to enhance their compactness, discreetness, wearability, etc., while also lowering their cost to manufacture. | 04-30-2015 |
20150351670 | FAULT DISCRIMINATION AND RESPONSIVE PROCESSING BASED ON DATA AND CONTEXT - Systems and methods disclosed here provide ways to discriminate fault types encountered in analyte sensors and systems and further provide ways to process such discriminated faults responsively based on sensor data, clinical context information, and other data about the patient or patient's environment. The systems and methods thus employ clinical context in detecting and/or responding to errors or faults associated with an analyte sensor system, and discriminating the type of fault, and its root cause, particularly as fault dynamics can appear similar to the dynamics of physiological systems, emphasizing the importance of discriminating the fault and providing appropriate responsive processing. Thus, the disclosed systems and methods consider the context of the patient's health condition or state in determining how to respond to the fault. | 12-10-2015 |
20150351671 | FAULT DISCRIMINATION AND RESPONSIVE PROCESSING BASED ON DATA AND CONTEXT - Systems and methods disclosed here provide ways to discriminate fault types encountered in analyte sensors and systems and further provide ways to process such discriminated faults responsively based on sensor data, clinical context information, and other data about the patient or patient's environment. The systems and methods thus employ clinical context in detecting and/or responding to errors or faults associated with an analyte sensor system, and discriminating the type of fault, and its root cause, particularly as fault dynamics can appear similar to the dynamics of physiological systems, emphasizing the importance of discriminating the fault and providing appropriate responsive processing. Thus, the disclosed systems and methods consider the context of the patient's health condition or state in determining how to respond to the fault. | 12-10-2015 |
20150351672 | FAULT DISCRIMINATION AND RESPONSIVE PROCESSING BASED ON DATA AND CONTEXT - Systems and methods disclosed here provide ways to discriminate fault types encountered in analyte sensors and systems and further provide ways to process such discriminated faults responsively based on sensor data, clinical context information, and other data about the patient or patient's environment. The systems and methods thus employ clinical context in detecting and/or responding to errors or faults associated with an analyte sensor system, and discriminating the type of fault, and its root cause, particularly as fault dynamics can appear similar to the dynamics of physiological systems, emphasizing the importance of discriminating the fault and providing appropriate responsive processing. Thus, the disclosed systems and methods consider the context of the patient's health condition or state in determining how to respond to the fault. | 12-10-2015 |
20150351673 | FAULT DISCRIMINATION AND RESPONSIVE PROCESSING BASED ON DATA AND CONTEXT - Systems and methods disclosed here provide ways to discriminate fault types encountered in analyte sensors and systems and further provide ways to process such discriminated faults responsively based on sensor data, clinical context information, and other data about the patient or patient's environment. The systems and methods thus employ clinical context in detecting and/or responding to errors or faults associated with an analyte sensor system, and discriminating the type of fault, and its root cause, particularly as fault dynamics can appear similar to the dynamics of physiological systems, emphasizing the importance of discriminating the fault and providing appropriate responsive processing. Thus, the disclosed systems and methods consider the context of the patient's health condition or state in determining how to respond to the fault. | 12-10-2015 |
20160081632 | METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT - Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations. | 03-24-2016 |
20160098539 | SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION - Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. | 04-07-2016 |
20160098540 | SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION - Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. | 04-07-2016 |
20160098848 | SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION - Systems and methods are described that provide a dynamic reporting functionality that can identify important information and dynamically present a report about the important information that highlights important findings to the user. The described systems and methods are generally described in the field of diabetes management, but are applicable to other medical reports as well. In one implementation, the dynamic reports are based on available data and devices. For example, useless sections of the report, such as those with no populated data, may be removed, minimized in importance, assigned a lower priority, or the like. | 04-07-2016 |
20160101232 | METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT - Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations. | 04-14-2016 |
Lindsey J. Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110018866 | STRUCTURE OF THE FARNESOID X RECEPTOR LIGAND BINDING DOMAIN AND METHODS OF USE THEREFOR - The present invention provides compositions comprising the ligand binding domain (LBD) of a farnesoid X receptor (FXR) in crystalline form. In alternative embodiments, the LBD of FXR is complexed with a ligand therefor. There are provided high resolution structures of FXR complexed with a novel high affinity agonist fexaramine. The discovered structure of a FXR LBD provides the first three-dimensional view of the structural basis for FXR ligand binding. The present invention further provides a computer for producing a time-dimensional representation of FXR or a complex thereof, and a computer for determining at least a portion of the structure coordinates of FXR or a complex thereof. The present invention further provides methods of using this structural information to predict molecules capable of binding to FXR; to identify compounds with agonist, antagonist or partial agonist activity for FXR; and to determine whether a test compound is capable of binding to the LBD of FXR. The present invention further provides compositions comprising compounds identified by such invention methods. | 01-27-2011 |
Lyle Bowman, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20090093449 | Concentrated aqueous azalide formulations - The present invention relates to formulations of concentrated azalide antibiotics and methods for making and using them. Specifically, the invention relates to a method of treating an infection comprising administering to a patient in need thereof, an effective amount of a concentrated aqueous azalide antibiotic formulation made according to the method comprising dissolving an azalide antibiotic in an aqueous solution comprising a strong acid. The invention also relates to methods for making concentrated aqueous azalide antibiotic formulations for use in pulmonary infection, a nasopharyngeal infection, an otic infection, an ocular infection, a dermal or a vaginal infection. The invention also relates to concentrated aqueous azalide antibiotic formulations made by dissolving an azalide antibiotic in an aqueous solution comprising a strong acid. | 04-09-2009 |
20090269391 | Drug Delivery System And Methods Of Use - Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers. | 10-29-2009 |
20090269392 | Drug Delivery System And Methods Of Use - Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers. | 10-29-2009 |
20100224657 | TIP ARRANGEMENT FOR A DROPPER BOTTLE - A tip arrangement for a bottle used for dispensing viscous liquid, such as drops of medicine, is provided. Embodiments include a tip insert having an insert body and a piercing point at a lower end of the insert body, for piercing a top surface of the bottle and for retaining the tip insert on the top surface of the bottle after piercing. A passage extends from a distal end of the piercing point, through the insert body, to an opposing upper surface of the insert body. A dispensing tip at the insert body upper surface communicates with the passage for precisely forming drops of the liquid from the bottle. | 09-09-2010 |
20100226997 | CONTROLLED-RELEASE OPHTHALMIC VEHICLES - An ophthalmically acceptable vehicle includes an aqueous suspension having a first viscosity. The suspension includes about 0.1% to about 6.5% by weight of a carboxyl-containing polymer prepared by polymerizing one or more carboxyl-containing monoethylenically unsaturated monomers and less than about 5% by weight of a cross-linking agent. The polymer has average particle size of not more than about 50 μm in equivalent spherical diameter. The vehicle includes a second polymer that allows the carboxyl-containing polymer to remain suspended. Upon contact with tear fluid, the vehicle gels to a second viscosity which is greater than the first viscosity. A method of administering a medicament to the eye of a subject includes applying a composition that includes this ophthalmically acceptable vehicle and a medicament contained for treatment of a disease or disorder for which ophthalmic delivery is indicated. The medicament is released from the vehicle in a sustained release manner. | 09-09-2010 |
20100227842 | METHODS FOR TREATING OCULAR INFLAMMATORY DISEASES - A method of treating blepharitis includes administering to the affected eye of a subject an effective amount of an active ingredient in an ophthalmically acceptable vehicle for a sufficient period of time to treat blepharitis. The active ingredient consists essentially of a glucocorticoid in an ophthalmically acceptable vehicle that includes an aqueous polymer suspension that when mixed with tear fluid provides a sustained release of said active ingredient. The aqueous polymer suspension includes a carboxyl-containing polymer having less than about 5% by weight cross-linking agent and has a viscosity in a range from about 1,000 to about 30,000 centipoises. A kit includes: (a) a composition comprising about 0.1% by weight dexamethasone in this ophthalmically acceptable vehicle and (b) instructions for using the composition of (a) for the treatment of blepharitis. | 09-09-2010 |
20100305054 | CONCENTRATED AQUEOUS AZALIDE FORMULATIONS - The present invention relates to formulations of concentrated azalide antibiotics and methods for making and using them. Specifically, the invention relates to a method of treating an infection comprising administering to a patient in need thereof, an effective amount of a concentrated aqueous azalide antibiotic formulation made according to the method comprising dissolving an azalide antibiotic in an aqueous solution comprising a strong acid. The invention also relates to methods for making concentrated aqueous azalide antibiotic formulations for use in pulmonary infection, a nasopharyngeal infection, an otic infection, an ocular infection, a dermal or a vaginal infection. The invention also relates to concentrated aqueous azalide antibiotic formulations made by dissolving an azalide antibiotic in an aqueous solution comprising a strong acid. | 12-02-2010 |
20130023575 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE ALLERGIES - The disclosure provides ophthalmic compositions, systems and methods for the treatment of ocular surface allergies. More particularly the present invention relates to compositions of bromfenac for the treatment of the signs and symptoms of ocular surface allergies due to seasonal allergies. | 01-24-2013 |
Lyle M. Bowman, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20100227928 | NON-STEROIDAL ANTI-INFLAMMATORY OPHTHALMIC COMPOSITIONS - The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye. | 09-09-2010 |
20130165419 | COMBINATION ANTI-INFLAMMATORY OPHTHALMIC COMPOSITIONS - Compositions and systems for topical ophthalmic application, which include an aqueous mixture of steroidal and non-steroidal anti-inflammatory agents in a flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye. | 06-27-2013 |
20130177599 | METHODS AND KITS FOR EXTENDING CONTACT LENS USE - Provided are method and kits useful for extending the wear-time of a contact lens. The method includes applying an amount of an ophthalmically acceptable solution to the contact lens to improve the comfort of the eye when the contact lens is in the eye. The solution includes an aqueous suspension and chitosan. The aqueous suspension includes about 0.1% to about 6.5% by weight of a carboxyl-containing polymer prepared by polymerizing one or more carboxyl-containing monoethylenically unsaturated monomers and less than about 5% by weight of a cross-linking agent. Upon contact with tear fluid, the solution gels to a second viscosity which is greater than the first viscosity. The kit includes contact lenses, an ophthalmically acceptable solution and instructions for applying the solution to improve the comfort of the eye when the contact lens is in the eye. | 07-11-2013 |
20130217657 | COMBINATION ANTI-INFLAMMATORY OPHTHALMIC COMPOSITIONS - Compositions and systems for topical ophthalmic application, which include an aqueous mixture of steroidal and non-steroidal anti-inflammatory agents in a flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye. | 08-22-2013 |
20140142055 | METHODS OF TREATING RECURRENT MEIBOMIAN GLANDS DISORDER AND THEREBY DECREASING THE FREQUENCY OF RECURRENCE - A method of treating a recurring meibomian gland disorder in a patient includes administering to a patient suffering from recurring meibomian gland disorder a composition comprising a therapeutically effective amount of an azalide antibiotic and a glucocorticoid. The method may thereby reduce the frequency of recurrence of the meibomian gland disorder. | 05-22-2014 |
20140274924 | CONCENTRATED AQUEOUS AZALIDE FORMULATIONS - Provided is concentrated aqueous azithromycin formulation from about from about 2%-20%, and a method of making a concentrated aqueous azithromycin formulation which includes preparing and sterilizing a first solution comprising a strong base to form a sterilized solution, dissolving the azithromycin in an aqueous solution comprising an acid consisting essentially of a strong acid, and adding the aqueous solution comprising the strong acid to the sterilized solution comprising the strong base. The strong acid has a pKa less than about −1.74 and the method is carried out without addition or use of a weak acid. | 09-18-2014 |
20150190407 | METHODS FOR TREATMENT OF POSTOPERATIVE INFLAMMATION WITH REDUCED INTRAOCULAR PRESSURE - Methods of treating a subject after ocular surgery are disclosed. The methods include administering to an eye of a subject in need thereof a composition comprising at least one corticosteroid or an ophthalmically acceptable salt thereof in an ophthalmically acceptable vehicle that can provide a sustained release of the at least one corticosteroid or an ophthalmically acceptable salt thereof. Advantageously, the composition does not result in a statistically significant elevation in intraocular pressure in a statistically significant number of subject eyes when administered twice daily over a period of two weeks. | 07-09-2015 |
Marianne Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090158468 | Metabolic engineering of lipid metabolism by improving fatty acid binding and transport - CHI like fatty acid binding proteins and genes, recombinant cells and organisms, methods of metabolic pathway engineering to improve lipid production in cells, Crystal structures of CHI like fatty acid binding proteins, methods of engineering CHI like fatty acid binding proteins and systems thereof are provided. | 06-18-2009 |
20100317030 | METHODS AND COMPOSITIONS FOR DETERMINING ENZYMATIC ACTIVITY - The present invention comprises crystalline polyketide synthases, isolated non-native polyketide synthases having the structural coordinates of said crystalline polyketide synthases, and nucleic acids encoding such non-native polyketide synthases. Also disclosed are methods of predicting the activity and/or substrated specificity of putative polyketide synthase, methods of identifying potential polyketide synthase substrates, and methods of identifying potential polyketide synthase inhibitors. | 12-16-2010 |
20110018866 | STRUCTURE OF THE FARNESOID X RECEPTOR LIGAND BINDING DOMAIN AND METHODS OF USE THEREFOR - The present invention provides compositions comprising the ligand binding domain (LBD) of a farnesoid X receptor (FXR) in crystalline form. In alternative embodiments, the LBD of FXR is complexed with a ligand therefor. There are provided high resolution structures of FXR complexed with a novel high affinity agonist fexaramine. The discovered structure of a FXR LBD provides the first three-dimensional view of the structural basis for FXR ligand binding. The present invention further provides a computer for producing a time-dimensional representation of FXR or a complex thereof, and a computer for determining at least a portion of the structure coordinates of FXR or a complex thereof. The present invention further provides methods of using this structural information to predict molecules capable of binding to FXR; to identify compounds with agonist, antagonist or partial agonist activity for FXR; and to determine whether a test compound is capable of binding to the LBD of FXR. The present invention further provides compositions comprising compounds identified by such invention methods. | 01-27-2011 |
20110223667 | METABOLIC ENGINEERING OF LIPID METABOLISM BY IMPROVING FATTY ACID BINDING AND TRANSPORT - CHI like fatty acid binding proteins and genes, recombinant cells and organisms, methods of metabolic pathway engineering to improve lipid production in cells, Crystal structures of CHI like fatty acid binding proteins, methods of engineering CHI like fatty acid binding proteins and systems thereof are provided. | 09-15-2011 |
Marianne E. Bowman, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080233628 | Incorporation of type III polyketide synthases into multidomain proteins of the type I and III polyketide synthase and fatty acid synthase families - Recombinant fusion proteins in which intermediates are covalently bound to the fusion proteins and transferred between domains of the fusion proteins are provided. The fusion proteins include proteins having type I polyketide or fatty acid synthase domains fused with type III polyketide synthase domains. Methods of making such recombinant fusion proteins and methods using such proteins to produce polyketide and other products are described. | 09-25-2008 |
20090011400 | Substrate switched ammonia lyases and mutases - Crystal structure information is used to make substrate-switched amino acid ammonia lyase enzymes, including TALs, PALs and HALs. Related methods, systems, compositions, cells and transgenic organisms are provided. | 01-08-2009 |
20090271888 | METHODS OF PRODUCING POLYKETIDE SYNTHASE MUTANTS AND COMPOSITIONS AND USES THEREOF - The present invention comprises crystalline polyketide synthases, isolated non-native polyketide synthases having the structural coordinates of said crystalline polyketide synthases, and nucleic acid encoding such non-native polyketide synthases. Also disclosed are methods of producing mutant polyketide synthases, and methods of altering the activity and/or substrate specificity of putative polyketide synthases. | 10-29-2009 |
20110020895 | METHODS AND COMPOSITIONS FOR DETERMINING ISOMERASE ENZYMATIC ACTIVITY - This disclosure provides crystalline flavonoid or flavanone isomerases, isolated non-native isomerase having the structural coordinates of said crystalline isomerase, and nucleic acids encoding such non-native isomerase. Also disclosed are methods of predicting the activity and/or substrate specificity of a putative isomerase, methods of identifying potential ismerase substrates, and methods of identifying potential isomerase inhibitors. | 01-27-2011 |
20120096581 | METHODS OF PRODUCING POLYKETIDE SYNTHASE MUTANTS AND COMPOSITIONS AND USES THEREOF - The present invention comprises crystalline polyketide synthases, isolated non-native polyketide synthases having the structural coordinates of said crystalline polyketide synthases, and nucleic acid encoding such non-native polyketide synthases. Also disclosed are methods of producing mutant polyketide synthases, and methods of altering the activity and/or substrate specificity of putative polyketide synthases. | 04-19-2012 |
20120122180 | INCORPORATION OF TYPE III POLYKETIDE SYNTHASES INTO MULTIDOMAIN PROTEINS OF THE TYPE I AND III POLYKETIDE SYNTHASE AND FATTY ACID SYNTHASE FAMILIES - Recombinant fusion proteins in which intermediates are covalently bound to the fusion proteins and transferred between domains of the fusion proteins are provided. The fusion proteins include proteins having type I polyketide or fatty acid synthase domains fused with type III polyketide synthase domains. Methods of making such recombinant fusion proteins and methods using such proteins to produce polyketide and other products are described. | 05-17-2012 |
Michael Bowman, Bakersfield, CA US
Patent application number | Description | Published |
---|---|---|
20130180002 | ONION VARIETY NUN 03010 ON - The invention relates to the field of | 07-11-2013 |
20140007274 | ONION VARIETY DULCIANA | 01-02-2014 |
20150319948 | ONION VARIETY NUN 2002 ON - The invention relates to the field of | 11-12-2015 |
Miles Alex Bowman, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20080303213 | Soccer game - The present invention is a novel table top soccer game that provides for variety in game play. Figurines may be manipulated by players in order to direct or block a spherical unit representing a soccer ball. The object of the game is to score a predetermined number of goals and the game may be played with or without cards that provide for variety in game outcome. | 12-11-2008 |
Reid Bowman, Ojai, CA US
Patent application number | Description | Published |
---|---|---|
20080302720 | Membrane biofilm reactor for removing contaminants from ground water - Apparatus and methods for water treatment are described, particularly for the simultaneous removal of nitrate, perchlorate, and other organic contaminates from contaminated water using a membrane biofilm reactor (MBfR). | 12-11-2008 |
20090095675 | Water treatment bioreactor using hollow filaments - Apparatus, systems, and methods for removal of contaminants in water are described. In particular, apparatus, systems, and methods for the treatment of potable water, for removal of oxidized contaminants, using hollow polyester filaments for sustaining a biofilm are described. | 04-16-2009 |
20100089827 | MEMBRANE BIOFILM REACTOR FOR REMOVING CONTAMINANTS FROM GROUND WATER - Apparatus and methods for water treatment are described, particularly for the simultaneous removal of nitrate, perchlorate, and other organic contaminates from contaminated water using a membrane biofilm reactor (MBfR). | 04-15-2010 |
20110186508 | MEMBRANE BIOFILM REACTOR FOR REMOVING CONTAMINANTS FROM GROUND WATER - Apparatus and methods for water treatment are described, particularly for the simultaneous removal of nitrate, perchlorate, and other organic contaminates from contaminated water using a membrane biofilm reactor (MBfR). | 08-04-2011 |
Reid H. Bowman, Ojai, CA US
Patent application number | Description | Published |
---|---|---|
20090039031 | Controlling the formation of hexavalent chromium during an oxidative remediation of a contaminated site - A method for inhibiting formation of hexavalent chromium during oxidative remediation of a contaminated site containing trivalent chromium is described. The method comprises introducing ozone at a first point to the contaminated site, where the ozone is introduced at a first frequency and for a first period of time, and introducing hydrogen peroxide to the contaminated site, where the hydrogen peroxide is introduced at a second frequency and for a second period of time. The first and second frequencies and first and second periods of time are selected to inhibit formation of hexavalent chromium within the site of remediation. | 02-12-2009 |
20110180474 | RADIAL FLOW MEMBRANE BIOFILM REACTOR - A membrane biofilm reactor (MBfR) device for treatment of water avoiding biofouling comprising: a central core tube having a wall defining a lumen and one or more perforations in the wall defining a perforated region, the core tube further having a first open end and second substantially closed end; a plurality of hollow filaments, each filament having a wall that defines an inner lumen, an exterior surface, a first end, and a second end; and a case having a cavity, a first end cap, a second end cap, and at least one effluent port; wherein the first open end of the core tube is sealed in the first end cap with the perforated region extending into the central cavity of the case, and wherein the first ends of the plurality of hollow filaments are open and sealed in the first end cap and the second ends of the plurality of hollow filaments are open and sealed in the second end cap. | 07-28-2011 |
20110186495 | APPARATUS, SYSTEMS, AND METHODS FOR WATER TREATMENT - An apparatus, system, and method relating to a modular water treatment apparatus that utilizes sidestream injection coupled to static mixing are described. The apparatus, system, and method utilizes ozone, with or without hydrogen peroxide, for effective disinfection and/or decontamination of contaminants present in waste water. The disinfected, decontaminated water is suitable for reuse. | 08-04-2011 |
Samuel R. Bowman, Colfax, CA US
Patent application number | Description | Published |
---|---|---|
20080250469 | Synchronized transmission of audio and video data from a computer to a client via an interface - A method for controlling data transmission between a computer and a video client via an interface, the method comprising: the computer polling the interface a first time to determine the size of the buffer on the interface; receiving a first buffer size value from the interface; sending a plurality of frames of video and audio data to the buffer on the interface such that a delay period exists between the sending of each frame; the computer polling the interface a second time to determine buffer size after the frames are sent to the interface; receiving a second buffer size value from the interface; and modifying the amount of time between the transmission of frames. | 10-09-2008 |
20110258675 | SYNCHRONIZED TRANSMISSION OF AUDIO AND VIDEO DATA FROM A COMPUTER TO A CLIENT VIA AN INTERFACE - A method for controlling data transmission between a computer and a video client via an interface, the method comprising: the computer polling the interface a first time to determine the size of the buffer on the interface; receiving a first buffer size value from the interface; sending a plurality of frames of video and audio data to the buffer on the interface such that a delay period exists between the sending of each frame; the computer polling the interface a second time to determine buffer size after the frames are sent to the interface; receiving a second buffer size value from the interface; and modifying the amount of time between the transmission of frames. | 10-20-2011 |
Sam W. Bowman, Valencia, CA US
Patent application number | Description | Published |
---|---|---|
20090149810 | Implantable Infusion Devices Including Apparatus For Confirming Fluid Flow And Systems, Apparatus And Methods Associated With Same - Implantable infusion apparatus, systems and methods that involve the use of a sensor that is associated with the catheter outlet. | 06-11-2009 |
20090221957 | Ambulatory Infusion Devices And Methods With Blockage Detection - Infusion devices with blockage detection capability and methods of monitoring infusion devices. | 09-03-2009 |
20120180571 | AMBULATORY INFUSION DEVICES AND METHODS - Infusion devices with blockage detection capability and methods of monitoring infusion devices. | 07-19-2012 |
20130197487 | Implantable Infusion Devices Including Apparatus For Confirming Fluid Flow And Systems, Apparatus And Methods Associated With Same - Implantable infusion apparatus, systems and methods that involve the use of a sensor that is associated with the catheter outlet. | 08-01-2013 |
Scott Bowman, Fairfax, CA US
Patent application number | Description | Published |
---|---|---|
20130300430 | ISOLATION MONITOR - An isolation monitor is disclosed in which a switchable bias voltage is imposed on a chassis ground. An isolation voltage is measured when a bias voltage is applied. When there are no electrical faults, the isolation voltage swings up and down to known values. When a fault occurs, the isolation voltage will not to swing to the known values, and thus the isolation resistance can be measured and alarm generated if the isolation resistance falls below a threshold value. | 11-14-2013 |